قالب وردپرس درنا توس
Home / Business / Five major takeaways from Roche's $ 5B purchase of Spark Therapeutics

Five major takeaways from Roche's $ 5B purchase of Spark Therapeutics



L a start with the biggest two messages: Roche's (RHHBY) takeover of $ 5 billion acquisition of Spark Therapeutics (ONCE) means that major pharmaceutical companies are at a full-fledged mall and that gene therapy, expected treatment approach of hereditary diseases, has made great time.

The Wall Street Journal reported Saturday that Roche was negotiating to buy Spark at a 150 percent premium to the smaller company's market value on Friday. On Monday morning, the two companies announced that Roche would buy Spark for $ 4.8 billion, or $ 1

14.50 per share. Here are five things to keep in mind this news for anyone who cares about the biotech industry.

Unlock this article by subscribing to STAT Plus and enjoy the first 30 days for free!

GOT STARTED


Source link